Dr Sanjay Agrawal, Scientific Advisor, ALKOMEX GBN PHARMA GROUP USA, elaborates that nutraceuticals aren’t just trendy- they reflect a shift toward proactive, empowered health
The last decade has witnessed a seismic shift in global health priorities, with a growing emphasis on prevention over cure. At the heart of this transformation lies a relatively new category of health products: nutraceuticals. Neither conventional food nor pharmaceutical drugs, these hybrid products are redefining how we approach wellness, and the trend is only accelerating.
Coined in 1989, nutraceutical merges nutrition and pharmaceuticals, covering products like supplements, functional foods, and probiotics that support health beyond basic nutrition. Unlike drugs, they focus on restoring balance with fewer side effects. For R&D teams, understanding category-specific regulations and clinical requirements is key to global market success.
The rise of nutraceuticals: Why now?
The COVID-19 pandemic wasn’t just a health crisis- it was a global wake-up call to the fragility of human immunity. As hospitals overflowed and vaccines were still underway, people turned to self-care, immunity boosters, and preventive wellness, driving a surge in demand for supplements like vitamin C, zinc, turmeric, ashwagandha, and elderberry. This shift fueled the nutraceutical boom, with the global market- valued at USD 352.92 billion in 2021- expected to reach USD 860.9 billion by 2030 (Grand View Research, 2022). India, backed by its rich traditions in Ayurveda and robust pharmaceutical sector, is projected to touch USD 18 billion by 2025 (FICCI, 2021).
So, what’s fuelling this unprecedented growth?
- Rise in lifestyle diseases
We’re living longer, but not necessarily healthier- chronic, non-communicable diseases (NCDs) now account for 74 per cent of all global deaths (WHO, 2022), including conditions like Type 2 diabetes, obesity, hypertension, heart disease, and certain cancers. Most of these are lifestyle-induced, stemming from poor diet, inactivity, and stress. Consumers are increasingly realising that prevention is both safer and more affordable than treatment, turning to nutraceuticals like omega-3s for heart health, probiotics for metabolic balance, and plant sterols for cholesterol control. For healthcare providers and insurers, integrating nutraceuticals into preventive care plans offers a scalable, cost-effective strategy to reduce the long-term burden of NCDs.
- Ageing populations and the silver economy
With the global population aged 60 and above projected to double to 2.1 billion by 2050 (UN, 2022), demand is rising for geriatric-focused nutraceuticals that address joint pain (glucosamine, collagen), memory (ginkgo biloba, B vitamins), bone health (calcium, vitamin D), and eye support (lutein, zeaxanthin). These older consumers prefer gentler alternatives with fewer side effects compared to pharmaceuticals. The need for customised dosage forms, improved bioavailability, and minimal drug interaction is also fueling new R&D pipelines within clinical nutrition and pharma sectors targeting the silver economy.
- Youth-led wellness movement
Millennials and Gen Z are rewriting the wellness playbook- investing heavily in preventive health with 80 per cent willing to pay more for it (McKinsey, 2021). With wearables, plant-based diets, and fitness apps, they view nutraceuticals as essential daily hacks- from collagen coffee to nootropic smoothies. This generation doesn’t wait to get sick- they biohack for immunity, skin, sleep, and performance. For brands, consumer behaviour analytics and social listening now shape everything from product formulation to influencer marketing, packaging, and digital storytelling geared toward these trend-driven, wellness-first buyers.
- Shift from curative to preventive healthcare models
Governments, insurers, and healthcare providers are shifting focus from reactive to preventive healthcare. With NCDs projected to cost the global economy $47 trillion by 2030 (World Economic Forum), prevention has become not just smarter health-wise, but more economical- every $1 spent yields $4 in future savings. Corporate wellness programs and hospital networks are now adopting nutraceutical-based protocols for lifestyle disease management, mental health, and recovery care. India’s Ayushman Bharat Digital Mission exemplifies this convergence, integrating traditional and modern medicine with nutraceuticals playing a central role.
- E-commerce boom and influencer culture
The pandemic fast-tracked the digital health economy, making online supplement shopping the norm- guided more by fitness influencers, YouTube reviews, and Instagram hacks than by physicians. Global e-commerce revenue in health and wellness hit USD 100 billion (Statista, 2023), and India’s D2C nutraceutical space is seeing triple-digit growth. Brands like Oziva and Kapiva are elevating product storytelling and scientific credibility. To stay competitive, industry leaders must double down on SEO optimisation, digital compliance, and science-backed narratives in an increasingly saturated digital marketplace.
- Global supply chain and innovation acceleration
Technological leaps are revolutionising nutraceutical innovation- from nanoencapsulation for better bioavailability, to AI-driven formulation engines, to blockchain for ingredient traceability. India, leveraging its pharma infrastructure, is emerging as a major global supplier of raw materials, ready formulations, and white-label products. Strategic partnerships between pharma, biotech, and AI startups are now critical for personalised, clean-label innovation- pushing the envelope in everything from gut health to cognitive performance.
- Mental health and holistic wellness
The wellness conversation has evolved beyond physical health to include emotional and cognitive resilience. Consumers are turning to adaptogens (ashwagandha, rhodiola) for stress, nootropics (L-theanine, bacopa) for focus, and mood-supporting nutrients (magnesium, saffron extracts) for emotional balance and sleep. This marks a move from body-only approaches to whole-self wellness. For formulators, this opens doors to explore adaptogen stacking, nootropic synergies, and neuro-nutritional therapy rooted in validated clinical frameworks.
Do nutraceuticals really work? The science behind the claims
Despite scepticism fueled by marketing hype and inconsistent regulation, the credibility of nutraceuticals hinges on solid scientific evidence. While alignment between CROs, academic bodies, and regulators is still a work in progress, many nutraceuticals are already backed by robust clinical data. Curcumin, omega-3 fatty acids, probiotics, resveratrol, ashwagandha, vitamin D, and calcium have all demonstrated proven benefits in areas like inflammation, cognition, immunity, hormonal balance, and bone health.
Coenzyme Q10 and folic acid show promise for migraines and pregnancy health, respectively. Thousands of peer-reviewed trials are now indexed on PubMed, and top institutions like Harvard and Mayo Clinic are actively exploring natural compounds alongside pharmaceuticals- bringing more legitimacy and depth to the science behind these products.
The Indian perspective: Blending ayurveda with modern science
India stands at a powerful crossroads where ancient traditions meet cutting-edge science. Ayurvedic herbs like ashwagandha, tulsi, moringa, and giloy are being transformed into globally accepted nutraceuticals through standardised formulations backed by the Ministry of AYUSH. Traditional remedies like kadha, haldi doodh, and chyawanprash are now being reimagined in formats like capsules, teas, and effervescent tablets, appealing to both rural and urban consumers. Initiatives like Make in India and Startup India are catalysing innovation and exports, while India’s strengths in biotech, pharma, and Ayurveda create a rare opportunity to lead the world in evidence-based traditional health solutions- if harmonisation with global GMP standards is prioritised.
The future of nutraceuticals
The next evolution lies in hyper-personalised nutrition- AI-driven, gene-based supplements tailored to individual health profiles. Smart packaging with QR-linked clinical data, sustainability-focused clean labels, and plant-based innovations are aligning with global trends in conscious consumerism. With over $200 million raised by Indian nutraceutical startups in 2023 alone, the sector is attracting cross-industry investment from biotech, genomics, and wellness. This convergence of Ayurveda, AI, and modern science is ushering in a new paradigm of preventive, personalised, and tech-enabled health- positioning nutraceuticals as key players in future healthcare ecosystems.
Conclusion: A pill for prevention, not just a cure
Nutraceuticals aren’t just trendy- they reflect a shift toward proactive, empowered health. Blending ancient wisdom with modern science, they offer sustainable support alongside conventional medicine. As awareness grows, so does the chance to shape a responsible, evidence-led future for global wellness. Every supplement is a quiet revolution in how we heal, prevent, and thrive.
References:
https://www.remedypublications.com/open-access/nutraceuticals-redefining-a-concept-4712.pdf
https://www.gminsights.com/industry-analysis/nutraceuticals-market
https://www.grandviewresearch.com/industry-analysis/nutraceuticals-market
https://www.skyquestt.com/report/nutraceuticals-market
https://ficci.in/public/storage/SPDocument/23536/innovation_food&Nutrition1.pdf
